Chagas disease, Visceral Leishmaniasis and Cutaneous Leishmaniasis. research hub

A clinical trial to learn more about the absorption of radiolabeled drug LXE408, how the body breaks it down, and how quickly the body gets rid of it in healthy men

This study looks at a new medicine, LXE408, for parasitic diseases like Chagas disease. It aims to understand how the medicine moves through healthy men's bodies, how it's broken down, and how quickly it leaves. Researchers also check for safety and side effects.